Patent · US Active

Crystalline forms

US8389510B2 · kind B2 · utility

4Cited by

11References

11Claims

0Family size

Assignee

ASTRAZENECA AB · SE

Inventors

Simon N. Black · Macclesfield, GB
Simon D. Broady · Grafton, GB
Alan S. Kirschner · Wilmington, US
James A. Osborn · Wilmington, US
Stewart D. Jolly · Bristol, GB
Dan B. Brown · Wilmington, US
Daniel Korey · Yardley, US
Karen B. Main · Wilmington, US
Richard J. R. Creekmore · Wilmington, US
Jean M. Surian · Wilmington, US
Vivian Y. Bi · Wilmington, US
Peter Bernstein · Wallingford, US
James B. Campbell · Wilmington, US
Greg Christoph · Wilmington, US
Scott W. Grimm · Wilmington, US
Dan Widzowski · Wilmington, US
James Hulsizer · Wilmington, US
Phil Edwards · Wilmington, US

Key dates

Filing date	Mar 18, 2010
Grant date	Mar 5, 2013
Priority date	—
Expiry date	Sep 21, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

11-piperazin-1-yldibenzo[b,f][1,4]thiazepine, compositions thereof, preparations thereof, formulations thereof, prodrugs thereof and pharmaceutical uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.